Keythera Pharmaceuticals
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $30M
Investors
- 6
About Keythera Pharmaceuticals
Keythera Pharmaceuticals is involved in the research and development of groundbreaking therapeutic solutions.Keythera Pharmaceuticals specializes in innovative small molecule drugs primarily aimed at treating oncology and autoimmune conditions. Its leading products include the EP4 receptor antagonist KF-0210, which is in Phase Ib clinical trials for solid tumors and has approved Phase II trials for osteoarthritis, and KBP-2205, focused on cancer treatment and having completed PCC validation studies. These products are based on the company’s proprietary Affinity Detection by Mass Spectroscopy (ADMS) platform, designed for high-throughput screening.Keythera Pharmaceuticals operates a revenue model centered on the development and commercialization of its pharmaceutical products through clinical trials and regulatory approvals. The company collaborates with healthcare institutions and pharmaceutical companies through research agreements and licensing deals.Keythera Pharmaceuticals plans to advance its pipeline with the ongoing development of KF-0210 and KBP-2205, targeting a broader range of oncology applications and exploring new indications by 2023.000 mn will support these initiatives, allowing the company to enhance its clinical trial capabilities and expand its research operations into international markets, thereby broadening its commercial footprint.
Who invested in Keythera Pharmaceuticals
6 investors across 2 rounds
See all investors in Keythera Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Keythera Pharmaceuticals
Who invested in Keythera Pharmaceuticals?
Keythera Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Keythera Pharmaceuticals raised?
Keythera Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Keythera Pharmaceuticals last raise money?
Keythera Pharmaceuticals's most recent round on record is a Series A, in Mar 2021.
What does Keythera Pharmaceuticals do?
Keythera Pharmaceuticals is involved in the research and development of groundbreaking therapeutic solutions.
Where is Keythera Pharmaceuticals headquartered?
Keythera Pharmaceuticals is headquartered in Suzhou, China.
Which VCs invest in companies like Keythera Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Keythera Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Keythera Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.